Champions Oncology Inc (CSBR) financials · rev $59.4M
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
Champions Oncology Inc (CSBR) rev $59.4M.
| Line | FY2026 | FY2025 |
|---|---|---|
| Revenue | $59.4M | $56.9M |
| Cost of Revenue | $30.9M | $28.4M |
| Gross Profit | $28.5M | $28.6M |
| Operating Income | -$1.14M | $4.55M |
| Net Income | -$1.18M | $4.70M |
| EPS (Diluted) | -$0.08 | $0.33 |
| Line | FY2026 | FY2025 |
|---|---|---|
| Total Assets | $27.0M | $32.3M |
| Current Assets | $19.2M | $22.4M |
| Cash & Equivalents | $4.87M | $9.79M |
| PP&E | $16.4M | $16.1M |
| Total Liabilities | $22.9M | $28.6M |
| Current Liabilities | $19.9M | $23.9M |
| Shareholders' Equity | $3.94M | $3.77M |
| Retained Earnings | -$81.1M | -$79.9M |
| Line | FY2026 | FY2025 |
|---|---|---|
| Operating Cash Flow | -$4.47M | $7.39M |
| CapEx | $564.0K | $389.0K |
| Investing Cash Flow | -$540.0K | -$389.0K |
| Financing Cash Flow | $99.0K | $170.0K |
| Net Change in Cash | -$4.91M | $7.17M |
| Free Cash Flow | -$5.04M | $7.00M |
FAQ
What is CSBR P/E and revenue?
Champions Oncology Inc (CSBR) rev $59.4M.
What is CSBR revenue?
Champions Oncology Inc last cached revenue is $59.4M (FY2026).
Is CSBR profitable?
Champions Oncology Inc last cached net income is -$1.18M (FY2026).
What are CSBR total assets?
Champions Oncology Inc last cached total assets are $27.0M (FY2026).
What is CSBR free cash flow?
Champions Oncology Inc last cached free cash flow is -$5.04M (FY2026).
Not investment advice. Cached statements, not a live tape.